Clinical Trial Update: A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety and tolerability of INCB160058 in participants with Myeloproliferative Neoplasms and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Drugs mentioned

• INCB160058

Snippet

Sponsor: Incyte Corporation | Conditions: Myeloproliferative Neoplasms | Phase 1 | Status: RECRUITING